Aurinia Pharmaceuticals Inc (AUPH)

Mar 12, 2026

Responsive Playbooks and the AUPH Inflection - Stock Traders Daily

Mar 12, 2026

Mar 12, 2026

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives Average Recommendation of "Hold" from Analysts - MarketBeat

Mar 12, 2026

Mar 11, 2026

Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Passes Below 50-Day Moving AverageShould You Sell? - MarketBeat

Mar 11, 2026

Mar 11, 2026

Aurinia Pharma’s Wild Ride: What AUR’s Lupus Bet Means For You - AD HOC NEWS

Mar 11, 2026

Mar 10, 2026

A Look At Aurinia Pharmaceuticals (AUPH) Valuation After Strong Growth And Optimistic 2026 Guidance - simplywall.st

Mar 10, 2026

Mar 10, 2026

The Bull Case For Aurinia Pharmaceuticals (AUPH) Could Change Following Strong 2025 Results And Upbeat 2026 Outlook - Sahm

Mar 10, 2026

Mar 08, 2026

Aurinia Pharmaceuticals Earnings Strength And Valuation Gap Attract Investor Attention - Sahm

Mar 08, 2026

Mar 06, 2026

Aug Breakouts: Why is Aurinia Pharmaceuticals Inc stock going upExit Point & Daily Oversold Bounce Ideas - baoquankhu1.vn

Mar 06, 2026

Mar 06, 2026

Aurinia Pharmaceuticals: Waiting For Another Opportunity (Downgrade) (NASDAQ:AUPH) - Seeking Alpha

Mar 06, 2026

Mar 05, 2026

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress - Zenopa

Mar 05, 2026

Mar 03, 2026

Aurinia Pharmaceuticals (NASDAQ:AUPH) Director Buys $7,224,981.61 in Stock - MarketBeat

Mar 03, 2026

Mar 03, 2026

Aurinia Pharmaceuticals Inc (AUPH): Investor Outlook Reveals 19.63% Potential Upside - DirectorsTalk Interviews

Mar 03, 2026

Mar 03, 2026

Tang Capital LPs tied to Aurinia (NASDAQ: AUPH) buy 900K shares - Stock Titan

Mar 03, 2026

Mar 03, 2026

Assessing Aurinia Pharmaceuticals (AUPH) Valuation After Recent Share Price Swings - simplywall.st

Mar 03, 2026

Mar 03, 2026

Tang Capital boosts Aurinia (AUPH) stake to 9.2% ownership - Stock Titan

Mar 03, 2026

Mar 03, 2026

Aurinia (NASDAQ: AUPH) CFO gets stock, options; covers tax bill - Stock Titan

Mar 03, 2026

Mar 03, 2026

Aurinia (AUPH) COO receives stock grants and settles taxes with shares - Stock Titan

Mar 03, 2026

Mar 03, 2026

Aurinia (NASDAQ: AUPH) CEO receives major option grant and withholds shares for taxes - Stock Titan

Mar 03, 2026

Mar 03, 2026

Aurinia (AUPH) CMO awarded new stock options and share grant - Stock Titan

Mar 03, 2026

Mar 03, 2026

Aurinia (AUPH) EVP gets stock awards and has shares withheld for taxes - Stock Titan

Mar 03, 2026

Mar 03, 2026

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Passes Key Growth Screener from "The Little Book That Makes You Rich" - ChartMill

Mar 03, 2026

Mar 03, 2026

GSA Capital Partners LLP Trims Stake in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Mar 03, 2026

Mar 02, 2026

Should Aurinia’s Surging 2025 Earnings and Upbeat 2026 Outlook Require Action From Aurinia (AUPH) Investors? - Yahoo Finance

Mar 02, 2026

Mar 01, 2026

Aurinia’s LUPKYNIS Strength And Aritinercept Progress Versus Valuation Signals - simplywall.st

Mar 01, 2026

Mar 01, 2026

Aurinia Pharmaceuticals (AUPH) Reports Financial Results for Three and Twelve Months Ended December 31, 2025 - Bitget

Mar 01, 2026

Mar 01, 2026

Understanding the Setup: (AUPH) and Scalable Risk - Stock Traders Daily

Mar 01, 2026

Mar 01, 2026

12 Cheap Biotech Stocks to Buy Now - Insider Monkey

Mar 01, 2026

Feb 28, 2026

How Aurinia Pharmaceuticals Inc. stock trades during market volatilityWeekly Trade Review & AI Driven Stock Movement Reports - mfd.ru

Feb 28, 2026

Feb 27, 2026

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 27, 2026

Feb 27, 2026

Aurinia Pharmaceuticals (AUPH) Earnings Spike Above Revenue Challenges Profit Quality Narratives - Sahm

Feb 27, 2026

Feb 27, 2026

Decoding Aurinia Pharmaceuticals Inc (AUPH): A Strategic SWOT In - GuruFocus

Feb 27, 2026

Feb 26, 2026

Aurinia Pharmaceuticals Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals (NASDAQ:AUPH) Posts Earnings Results - MarketBeat

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals (AUPH) Stock Drops After Strong Quarter, Softer Forward Revenue Targets - Fidelity

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals Q4 Earnings Call Highlights - MarketBeat

Feb 26, 2026

Feb 26, 2026

AUPH: LUPKYNIS posted robust 2025 growth, with 2026 guidance reflecting continued momentum and market expansion - TradingView

Feb 26, 2026

Feb 26, 2026

Earnings call transcript: Aurinia Pharmaceuticals Q4 2025 earnings beat expectations - Investing.com

Feb 26, 2026

Feb 26, 2026

AUPH: LUPKYNIS sales and net income surged in 2025, with double-digit growth expected in 2026 - TradingView

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals : Corporate Presentation (Aurinia Corporate Presentation February 2026) - marketscreener.com

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 26, 2026

Feb 26, 2026

Aurinia Results Highlight LUPKYNIS Momentum And New Aritinercept Growth Option - Yahoo Finance

Feb 26, 2026

Feb 26, 2026

Earnings Breakdown: Aurinia Pharmaceuticals Q4 - Benzinga

Feb 26, 2026

Feb 26, 2026

Q4 2025 Earnings Call - marketscreener.com

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals (AUPH) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals Experiences Revision in Its Stock Evaluation Amid Strong Performance Indicators - Markets Mojo

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals Inc. Provides Earnings Guidance for the Year 2026 - marketscreener.com

Feb 26, 2026

Feb 26, 2026

AUPH Stock Gains On Aurinia Pharma’s Q4 Beat, But 2026 Guidance Misses Estimates - Stocktwits

Feb 26, 2026

Feb 26, 2026

Aurinia Lifts Revenue on LUPKYNIS Growth, Sets Strong 2026 Sales Outlook - TipRanks

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals Q4 Earnings, Revenue Rise; 2026 Revenue Outlook Set - marketscreener.com

Feb 26, 2026

Feb 26, 2026

AUPH: LUPKYNIS sales and net income soared in 2025, with strong growth and robust 2026 guidance - TradingView

Feb 26, 2026

Feb 26, 2026

Aurinia Lifts Profits on LUPKYNIS Growth and Sets Double-Digit 2026 Revenue Outlook - TipRanks

Feb 26, 2026

Feb 26, 2026

AURINIA PHARMACEUTICALS ($AUPH) Releases Q4 2025 Earnings - Quiver Quantitative

Feb 26, 2026

Feb 26, 2026

(AUPH) Aurinia Pharmaceuticals Expects Full Year 2026 Revenue Range $315M$325, vs. FactSet Est of $326.8M - marketscreener.com

Feb 26, 2026

Feb 26, 2026

Earnings Flash (AUPH) Aurinia Pharmaceuticals Posts Q4 EPS $1.53 - marketscreener.com

Feb 26, 2026

Feb 26, 2026

Earnings Flash (AUPH) Aurinia Pharmaceuticals Inc. Reports Q4 Revenue $77.1M, vs. FactSet Est of $74.7M - marketscreener.com

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals Inc announces its financial results for the fourth quarter and full year ended December 31, 2025 - Bitget

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals Inc. SEC 10-K Report - TradingView

Feb 26, 2026

Feb 26, 2026

Aurinia: Q4 Earnings Snapshot - marketscreener.com

Feb 26, 2026

Feb 26, 2026

Form 10-K Aurinia Pharmaceuticals For: Dec 31 - StreetInsider

Feb 26, 2026

Feb 26, 2026

Profit surge as Aurinia (NASDAQ: AUPH) raises 2026 LUPKYNIS outlook - Stock Titan

Feb 26, 2026

Feb 26, 2026

Earnings Summary: Aurinia Pharmaceuticals Q4 - Benzinga

Feb 26, 2026

Feb 26, 2026

BRIEF-Aurinia Pharmaceuticals Q4 Product Revenue USD 74.173 Million - TradingView

Feb 26, 2026

Feb 26, 2026

Canada's Aurinia Pharma Q4 revenue jumps on LUPKYNIS demand - TradingView

Feb 26, 2026

Feb 25, 2026

Earnings Preview: Aurinia Pharmaceuticals - Benzinga

Feb 25, 2026

Feb 25, 2026

Aurinia earnings on deck: Can lupus drug sustain growth momentum? By Investing.com - Investing.com Australia

Feb 25, 2026